Getinge’s decision to leave the surgical perfusion market will benefit LivaNova, an already dominant player in the sector that is set to capture market share, according to GlobalData experts ...

Getinge plans to phase out its surgical perfusion business in a move expected to benefit major players such as LivaNova, which are looking to strengthen their positions in the cardiopulmonary ...

EAST WINDSOR, NJ — Local elected officials recently gathered to celebrate the grand opening of the life science company, Getinge. Getinge’s new 165,500-square-foot building is located in the ...